Crowdonomics
WatchlistPortfolio
All companies
DelNova logo

DelNova

Operating

DelNova, Inc.

Healthcare · Founded 2018

Visit website

Solving botulinum toxin treatment complications

Valuation cap ⓘ
$10.0M
As of Jun 2022 · from Reg CF Offering (2022) · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$810,246
Crowd $0 · Private $810K · 2 rounds since 2018
Latest share price
$0.35
Rule 506(b) · Preferred Stock · Mar 2018 offering price

Financials

FY2019–FY2021 · from SEC filings · hover any figure for its source
$0
−$177K
2019
$22
−$136K
2020
$5K
−$48K
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019 reviewed
FY2020 reviewed
FY2021 reviewed
Income statement
Revenue
$0
$22
$5,252
Cost of goods sold
$0
$0
$0
Gross margin
—
100%
100%
Net income
-$176,613
-$136,033
-$47,587
Taxes paid
$0
$0
$0
Balance sheet
Cash
$328,363
$95,158
$52,638
Accounts receivable
$0
$0
$0
Total assets
$635,796
$499,257
$511,090
Short-term debt
$775
$271
$209
Long-term debt
$0
$0
$59,482
Total liabilities
$775
$271
$59,691
Other
Headcount
—
5
5

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Valuation caps on SAFE / convertible note rounds
$10.0M
Valuation cap
Reg CF · Note · Mar 2022

Dashed amber bars are a SAFE or convertible note's valuation cap — the most it converts at, not what the company is worth.

Fundraising history

Reg CF · Convertible Note · Mar 2022Withdrawnvia StartEngine
Raised $2.9K / $500KInvestors 5Valuation cap $10M
Rule 506(b) · Preferred Stock · Mar 2018Closed
Raised $810.2KInvestors 3

Team

2 people
Mary Gardner
CEO, Director/Board Member, Principal Financial Officer
Daniel Bradbury
Board Director

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not obligated

never closed a Reg CF raise

5 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-WSep 2, 20220001665160-22-002346
    EDGAR
  • Form C/AApr 29, 20220001665160-22-001174
    EDGAR
  • Form C-ARApr 26, 20220001665160-22-000831
    EDGAR
  • Form C/AApr 26, 20220001665160-22-000835
    EDGAR
  • Form CMar 30, 20220001665160-22-000575
    EDGAR
  • Form DApr 2, 20180001735668-18-000001
    EDGAR
Source: ManualCIK 0001735668Share price $0.35

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.